Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.

Abstract

Our results indicate that methylation of Cyclin D2 in prostate cancers correlates with clinicopathological features of poor prognosis. These findings are of biological and potential clinical importance.